Prof. Giorgi Pkhakadze, MD, MPH, PhD
GLP-1 Drugs Like Ozempic Cut Heart Attack Risk by 20% in Major Review
Major international review finds GLP-1 drugs like Ozempic reduce heart attack risk by 20% and stroke risk by 18%. The…
2025-2030 Dietary Guidelines Spark Scientific Controversy Over Evidence Standards
The 2025-2030 Dietary Guidelines for Americans have sparked unprecedented scientific controversy over evidence standards and methodology. Nutrition researchers are publicly…
Meta-Analysis Reveals First Biochemical Signature Common Across Multiple Anxiety Disorders
Brain-imaging meta-analysis reveals first consistent biochemical signature across multiple anxiety disorders, showing opposite metabolic patterns compared to other psychiatric conditions.…
Magnesium Supplements: Evidence Challenges Marketing Claims About Tissue-Specific Benefits
Popular marketing claims about tissue-specific magnesium supplements lack human evidence. Research shows multiple forms provide similar cognitive and sleep benefits,…
Over 100 Trials on Nicotine and Cognition Leave Daily Use Question Unanswered
More than 100 controlled trials have studied nicotine's cognitive effects, yet none examined daily use in healthy individuals for enhancement.…
Light Smoking Doubles Heart Disease Risk Even With Just Two Cigarettes Daily
New research shows smoking just 2-5 cigarettes daily increases heart failure risk by 50% and mortality by 60%. Even decades…
Magnesium Form May Not Matter for Cognitive Benefits, New Meta-Analysis Suggests
New meta-analysis suggests total magnesium intake matters more than specific supplement forms for cognitive benefits. Long-term research shows no meaningful…
FDA Recalls Omnicell Syringe Labels After Automated Compounding System Failures
FDA recalls Omnicell syringe labels for automated compounding systems after label detection failures that could result in mislabeled sterile medications.…